Erb-b2 Receptor Tyrosine Kinases, antagonists & inhibitors

All categories
DBCAT006055Pharmacologic class

A DrugBank category of 3 drugs. 1 of them is approved.

Drugs

What you can answer from here — as of March 06, 2026

3DrugsEach linked to its full drug card
Listed above
2Drug targetsEvery drug–target pair in the class, with bond type
Sign in
28Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
3Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Erb-b2 Receptor Tyrosine Kinases, antagonists & inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In